Signify Bio Launches With $15 Million Initial Financing
4 Articles
4 Articles


Dallas' Signify Bio Launches With Oversubscribed $15M Financing, Partnership With UT Southwestern
Dallas Innovates, Every Day: Here's what's new + next in North Texas. Dallas-based biotech company Signify Bio has launched with an oversubscribed $15 million initial financing round. The round was led by by Actium Group with participation from the Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, a subsidiary of Danaher Corporation, Eli Lilly and Co.,…The post Dallas’ Signify Bio Launches With Oversubscribed $15M Financing, Part…
Signify Bio Raises $15M in Initial Financing
Signify Bio, a Dallas, TX-based biotechnology company harnessing the human body for the production of in situ protein therapeutics, raised $15M in initial funding. The round was led by Actium Group with participation from the Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, a subsidiary of Danaher Corporation, Eli Lilly and Company, and BrightEdge, the […] The post Signify Bio Raises $15M in Initial Financing appeared first on F…
Signify Bio Launches With $15 Million Initial Financing
DALLAS–(BUSINESS WIRE)–Signify Bio, a pioneering biotechnology company harnessing the human body for the production of in situ protein therapeutics, today announced an oversubscribed $15 million initial financing. The round was led by Actium Group with participation from the Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, a subsidiary of Danaher Corporation, Eli Lilly and Company, and BrightEdge, the American Cancer Society’s (…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage